Document Detail


Tissue plasminogen activator in peripheral arterial thrombolysis.
MedLine Citation:
PMID:  2107957     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Thirty acute peripheral arterial thromboses in 28 patients were treated with local low-dose intra-arterial recombinant tissue plasminogen activator (t-PA). All patients received 0.5 mg h-1 t-PA and 15 also received 250 units h-1 of intra-arterial heparin. Overall limb salvage at 30 days was 83 per cent (25 out of 30 limbs). Mean(s.d.) ankle/brachial index was increased by 0.53(0.26) and there was no significant difference between the group receiving t-PA alone and that receiving t-PA and heparin. No strokes or major haemorrhages occurred but there were four (13 per cent) minor haematomas associated with the catheter entry site. There were four (13 per cent) deaths from myocardial infarction occurring between 5 and 21 days after treatment. Rethrombosis occurred in four cases (13 per cent). In two patients following t-PA alone, rethrombosis occurred after 2 and 11 days. Limb salvage was achieved with a successful repeat thrombolysis and a femoropopliteal graft respectively. Rethrombosis after t-PA and heparin occurred after 30 days in two patients due to poor run-off and extensive proximal atheromatous disease respectively. t-PA is a safe, effective thrombolytic agent when given as a low-dose intra-arterial infusion. The addition of low-dose heparin does not produce any significant benefit.
Authors:
D C Berridge; R H Gregson; G S Makin; B R Hopkinson
Related Documents :
1737287 - Laser-assisted angioplasty for arterial occlusion of the lower limb: initial results an...
2961397 - Transluminal angioplasty versus conventional operation in the treatment of haemodialysi...
3219547 - Testicular torsion in bristol: a 25-year review.
9688197 - Epidemiology and mortality of burns in tehran, iran.
17639167 - Characteristics of chlamydia trachomatis infection in hospitalized infants with lower r...
1680427 - Three years of experience with the swan-neck tenckhoff catheter.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The British journal of surgery     Volume:  77     ISSN:  0007-1323     ISO Abbreviation:  Br J Surg     Publication Date:  1990 Feb 
Date Detail:
Created Date:  1990-05-03     Completed Date:  1990-05-03     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0372553     Medline TA:  Br J Surg     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  179-82     Citation Subset:  AIM; IM    
Affiliation:
Department of Vascular Surgery, University Hospital, Nottingham, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Aged
Arterial Occlusive Diseases / drug therapy*
Humans
Leg / blood supply
Recombinant Proteins / therapeutic use
Recurrence
Thrombolytic Therapy*
Thrombosis / drug therapy*
Tissue Plasminogen Activator / administration & dosage,  therapeutic use*
Chemical
Reg. No./Substance:
0/Recombinant Proteins; EC 3.4.21.68/Tissue Plasminogen Activator
Comments/Corrections
Comment In:
Br J Surg. 1990 Aug;77(8):954-5   [PMID:  2118409 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Synthesis of prostaglandins I2 and E2 by the canine gallbladder in vitro: studies using a new incuba...
Next Document:  Effects of an amino acid solution enriched with either branched chain amino acids or ornithine-alpha...